Firstly no one is pumping nothing because the company is an 8 million dollar EV with 10 million in cash which there is nothing to pump because it’s already severely undervalued and nothing has been priced in for a drug that works beyond initial modelling and out paced all initial results.
Secondly of course for a stroke there is a limited time window and hence why all hospitals, ambulances and doctors all around the world will have this on hand hence the multi billion dollar market they dominate
Thirdly from his recent interview 4 days ago the CEO clearly stated that the Walter reed will still be completed on time and that on completion a partnership of non dilutive funding is in consideration with the US Army which are the ones that are driving the traumatic brain injury
Fourthly if you believe that a company with a drug exceeding all parameters and companies with less superior drugs trading at 70 million dollar market caps with less cash is a 8 million dollar EV you better keep bashing the keyboard that I’m pumping a company not pricing in anything. It’s a 100 million dollar market cap with the results it’s on and with a multi billion dollar run way as each phase study comes into play. The previous all time high before any of these results where know will be taken out. The same road of growth as MSB which you are invested in which was worth 4 billion dollars on a phase 3 potential 2 years ago. Doesn’t go from 8 million dollar EV to a 2-3 billion dollar valuation in a day
(20min delay)
